MFDS
- Status: likely_approved
🇰🇷 Decabid in South Korea
Decabid (INDECAINIDE) regulatory status in South Korea.
Marketing authorisation
Decabid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Decabid approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Decabid in South Korea?
Eli Lilly is the originator. The local marketing authorisation holder may differ — check the official source linked above.